Invoke Capital

Luminance is a company that specializes in an AI-powered platform for the generation, negotiation, and analysis of contracts. The platform employs a proprietary legal language model that enhances the processing and comprehension of legal documents, prioritizing accuracy and compliance. By integrating generative and analytical AI, Luminance aids organizations in optimizing contract-related workflows. Its technology leverages various machine learning techniques, including natural language processing and deep neural networks, enabling clients to effectively read and understand a wide range of legal materials. Luminance serves businesses across multiple industries, helping to streamline the review and decision-making processes associated with legal documentation.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

SOPHiA GENETICS is a healthcare technology company focused on advancing data-driven medicine and enhancing life sciences research. The company has developed the SOPHiA DDM™ Platform, a cloud-based software-as-a-service solution that analyzes complex multimodal data sets and various diagnostic modalities. This platform is utilized by over 780 hospitals, laboratories, and biopharma institutions worldwide. Headquartered in Switzerland, SOPHiA GENETICS also maintains a presence in France, the United States, and Brazil, underscoring its commitment to improving healthcare outcomes through innovative technology.

Luminance is a company that specializes in an AI-powered platform for the generation, negotiation, and analysis of contracts. The platform employs a proprietary legal language model that enhances the processing and comprehension of legal documents, prioritizing accuracy and compliance. By integrating generative and analytical AI, Luminance aids organizations in optimizing contract-related workflows. Its technology leverages various machine learning techniques, including natural language processing and deep neural networks, enabling clients to effectively read and understand a wide range of legal materials. Luminance serves businesses across multiple industries, helping to streamline the review and decision-making processes associated with legal documentation.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.

Neurence Limited, based in Cambridge, United Kingdom, develops self-learning artificial intelligence software solutions that enable devices to understand and react to their environments. Founded by a team of mathematicians and software engineers, Neurence has created a cloud-based platform that functions as a central repository for information. This platform allows devices to outsource processing tasks to Neurence’s intelligent cloud, enhancing their ability to perceive and respond to various situations. By leveraging advanced mathematical and computational algorithms, Neurence enables connected devices to access its extensive knowledge base, which continually evolves through machine learning. As devices share sensory data, Neurence learns from collective experiences, optimizing responses based on historical outcomes. This innovative approach results in devices that are lighter, faster, and more cost-effective to manufacture, while also improving their overall efficiency in real-world applications.

SOPHiA GENETICS is a healthcare technology company focused on advancing data-driven medicine and enhancing life sciences research. The company has developed the SOPHiA DDM™ Platform, a cloud-based software-as-a-service solution that analyzes complex multimodal data sets and various diagnostic modalities. This platform is utilized by over 780 hospitals, laboratories, and biopharma institutions worldwide. Headquartered in Switzerland, SOPHiA GENETICS also maintains a presence in France, the United States, and Brazil, underscoring its commitment to improving healthcare outcomes through innovative technology.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.